01 6Kymriah
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 474
2019 Revenue in Millions : 278
Growth (%) : 71
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 587
2020 Revenue in Millions : 474
Growth (%) : 24
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 536
2021 Revenue in Millions : 587
Growth (%) : -9
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 508
2022 Revenue in Millions : 536
Growth (%) : -5
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 76
2017 Revenue in Millions : 6
Growth (%) : 1167%
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 278
2018 Revenue in Millions : 76
Growth (%) : 266
